Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 1
2020 2
2021 4
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Post COVID-19 irritable bowel syndrome.
Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjölund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Sabatino A, Maggio M, Philippou E, Lee YY, Salvi D, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G; GI-COVID19 study group. Marasco G, et al. Gut. 2022 Dec 9:gutjnl-2022-328483. doi: 10.1136/gutjnl-2022-328483. Online ahead of print. Gut. 2022. PMID: 36591612
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.
Poloznikov AA, Nersisyan SA, Hushpulian DM, Kazakov EH, Tonevitsky AG, Kazakov SV, Vechorko VI, Nikulin SV, Makarova JA, Gazaryan IG. Poloznikov AA, et al. Among authors: vechorko vi. Front Pharmacol. 2021 Jan 29;11:621054. doi: 10.3389/fphar.2020.621054. eCollection 2020. Front Pharmacol. 2021. PMID: 33584306 Free PMC article. Review.
COVID-19-associated inhibition of energy accumulation pathways in human semen samples.
Adamyan L, Elagin V, Vechorko V, Stepanian A, Dashko A, Doroshenko D, Aznaurova Y, Sorokin M, Suntsova M, Drobyshev A, Garazha A, Buzdin A. Adamyan L, et al. Among authors: vechorko v. F S Sci. 2021 Nov;2(4):355-364. doi: 10.1016/j.xfss.2021.07.004. Epub 2021 Aug 5. F S Sci. 2021. PMID: 34377996 Free PMC article.
Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.
Shkurnikov M, Nersisyan S, Jankevic T, Galatenko A, Gordeev I, Vechorko V, Tonevitsky A. Shkurnikov M, et al. Among authors: vechorko v. Front Immunol. 2021 Feb 23;12:641900. doi: 10.3389/fimmu.2021.641900. eCollection 2021. Front Immunol. 2021. PMID: 33732261 Free PMC article.
[FEATURES OF THE USE OF ANTIBACTERIAL DRUGS IN PATIENTS WITH COVID-19].
Kryukov AV, Kuznetsova EV, Temirbulatov II, Vechorko VI, Zhuravleva MV. Kryukov AV, et al. Among authors: vechorko vi. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2022 Dec 15;30(s1):1044-1049. doi: 10.32687/0869-866X-2022-30-s1-1044-1049. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2022. PMID: 36385072 Russian.
15 results